Myelofibrosis Video Channel

Explore the latest insights and summaries from experts in Myelofibrosis.

Treatment Landscape

Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

FEATURING Ayalew Tefferi
  • 1,322 views
  • May 3, 2024
  • 13

Vanderbilt University Medical Center (VUMC)

Management of MF After Ruxolitinib Failure

FEATURING Ashwin Kishtagari
  • 191 views
  • July 18, 2024
  • 2

Indy Hematology Review

2024 Updates on Myelofibrosis and Systemic Mastocytosis

FEATURING Raajit Rampal
  • 330 views
  • April 16, 2024
  • 1

Memorial Sloan Kettering Cancer Center

Key Updates in AML, MDS, & MF From ASH

FEATURING Aaron Goldberg
  • 300 views
  • May 2, 2024
  • 4

Moffitt Cancer Center

Current Treatment Landscape of JAK Inhibitors in MF

FEATURING Andrew Kuykendall
  • 235 views
  • May 13, 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates in Myeloproliferative Neoplasms

FEATURING Elizabeth Hexner
  • 309 views
  • March 3, 2024
  • 1

UChicago Medicine

Overview of Recent Updates in MPNs and MDS

FEATURING Satyajit Kosuri
  • 280 views
  • March 20, 2024
  • 3

Insights from 2024 EHA Annual Meeting

Top 5 Impactful MPN Abstracts From Summer Conferences

FEATURING Prithviraj Bose
  • 158 views
  • July 31, 2024

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Highlights in Heme Malignancies

  • 456 views
  • September 23, 2024
  • 2

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Takeaways"

FEATURING Ruben Mesa
  • 362 views
  • January 19, 2024
  • 3

Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implications"

FEATURING Douglas Tremblay
  • 406 views
  • January 26, 2024

Winship Cancer Institute - Emory University

Updates on Myeloproliferative Neoplasms Including CML

FEATURING Anthony Hunter
  • 138 views
  • May 7, 2024

MyCancerHaven

Experts Discuss How They Choose 2L Therapy in MF

  • 157 views
  • August 30, 2024

SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: MPN

FEATURING John Mascarenhas
  • 249 views
  • March 22, 2024

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Key Biological and Clinical Developments in MPNs

FEATURING Tariq Mughal
  • 109 views
  • February 16, 2024

University of Colorado Division of Hematology

2024 Updates in MF

FEATURING Brandon McMahon
  • 76 views
  • April 19, 2024
  • 1

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Advances and Unmet Needs in MPN Treatment

FEATURING Daniela Cilloni
  • 80 views
  • February 21, 2024

Total Health

West Oncology Conference: Overview and Updates in MPNs

FEATURING Jason Chandler
  • 109 views
  • January 8, 2024

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Updates in the Prognosis and Treatment of Myelofibrosis

  • 31 views
  • February 21, 2024

Therapeutic Agents

Moffitt Cancer Center

Current Treatment Landscape of JAK Inhibitors in MF

FEATURING Andrew Kuykendall
  • 235 views
  • May 13, 2024

Vanderbilt University Medical Center (VUMC)

Management of MF After Ruxolitinib Failure

FEATURING Ashwin Kishtagari
  • 191 views
  • July 18, 2024
  • 2

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Advances and Unmet Needs in MPN Treatment

FEATURING Daniela Cilloni
  • 80 views
  • February 21, 2024

Icahn School of Medicine at Mount Sinai

Targeting Mutant Calreticulin in MPN

FEATURING Ann Mullally
  • 45 views
  • July 2, 2024

Icahn School of Medicine at Mount Sinai

Strategies to Overcome Immune Dysregulation in MPNs

FEATURING Cansu Cimen Bozkus
  • 30 views
  • July 2, 2024

Icahn School of Medicine at Mount Sinai

Leveraging Dysregulated Signaling Networks for Therapeutic Benefit in Myeloid Malignancies

FEATURING Stephen Oh
  • 19 views
  • July 2, 2024

Diagnostics & Biomarkers

Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

FEATURING Ayalew Tefferi
  • 1,322 views
  • May 3, 2024
  • 13

UChicago Medicine

Overview of Recent Updates in MPNs and MDS

FEATURING Satyajit Kosuri
  • 280 views
  • March 20, 2024
  • 3

University of Colorado Division of Hematology

2024 Updates in MF

FEATURING Brandon McMahon
  • 76 views
  • April 19, 2024
  • 1

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Updates in the Prognosis and Treatment of Myelofibrosis

  • 31 views
  • February 21, 2024

Disease Overview

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Key Biological and Clinical Developments in MPNs

FEATURING Tariq Mughal
  • 109 views
  • February 16, 2024

Icahn School of Medicine at Mount Sinai

Stem Cell Pathways, Aging, and Cancer Evolution in MPN

FEATURING Catriona Jamieson
  • 19 views
  • July 2, 2024

XV Eurasian Hematology-Oncology Congress - EHOC 2024

Retrospective Analysis of Primary MF Patients in Azerbaijan

FEATURING Elmir Guluyev
  • 11 views
  • September 16, 2024

Case Studies

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Updates in the Prognosis and Treatment of Myelofibrosis

  • 31 views
  • February 21, 2024

XV Eurasian Hematology-Oncology Congress - EHOC 2024

Myelofibrosis Case Discussion: Patient With Splanchnic Venous Thrombosis

FEATURING Weronika Lebowa
  • 14 views
  • September 25, 2024